Wearable Injector Market To Gather Huge Revenues By 2026 Estimated By Global Players Medtronic Plc, Becton, Dickinson And Company, Johnson & Johnson, Enable Injections, scPharmaceuticals, Inc, Insulet Corporation, Sensile Medical Ag

Drugs are mostly viscous and has various formulations (intravenous, intramuscular, and subcutaneous) that needs to be absorbed into digestive tract, which raise multiple drug delivery issue with traditional drug delivery system. Moreover, such issues not only raise costs but also decrease satisfaction and compliance of patients. Wearable injectors or bolus injectors are the new class for drug delivery device designed for subcutaneous delivery. It has capacity to hold the drug volume of up to 2.5 ml. Wearable injectors are easy to handle, low cost, disposable, and allow self-administration. Advancement in injector technology over traditional drug delivery system include single button to release the drug and after completion of drug in body, the needle is retracted and gets locked automatically. Thus, it’s safe and convenient disposable system benefits people who has needle phobia. Furthermore, it allows audible and visual signals, which is expected to fuel the growth of wearable injector market during forecast period.

Request For In-Depth Sample Copy @ https://bit.ly/2ElPpKa

Wearable Injector Market Taxonomy:

By Product type: On-body (Adhesive patch), Off-body (Belt clip), Hand-Held
By Usage: Disposable, Semi-Reusable
By Technology: Spring-based, Motor-driven, Rotary Pump, Expanding battery, Pressurized Gas, Collapsible Reservoir
By Application: Cardiovascular, Autoimmune diseases, Diabetes, Oncology, Infectious Diseases, Others
By End-use Industry: Hospital, Clinics, Home-care, Ambulatory Service

Strategies to improve drug delivery system through the introduction of new wearable injectors is expected to propel the growth of wearable injector market

In 2015, Unilife Corporation introduced Imperium, which is an instant patch pump used for insulin. Imperium is a subcutaneous insulin infusion, disposable, prefilled, and multi-day wearable insulin pump. It has various features that include data connectivity for app to constantly remind and update wireless connectivity such as Bluetooth LE. It also provide real-time access to healthcare provider to track the insulin therapy of each patient.

In 2014, Enable Injections LLC has signed an agreement with CSL Behring to develop novel drug delivery devices. Enable Injectors intent to improve comfort, convenience, and compliance administrative device for the patients with rare diseases.

Enable Injection LLC and Flex entered in agreement to develop and manufacture wearable medical device in 2016. Enable and Flex aims to develop subcutaneous pain-free injection technology with features such as Bluetooth connectivity, monitoring system with smartphone app, mix automation, and passive warming system.

Some of the key players operating in the global wearable injector market include;

1. Medtronic Plc
2. West Pharmaceutical Services, Inc.
3. Enable Injections
4. F. Hoffmann-La Roche Ltd
5. scPharmaceuticals, Inc
6. Johnson & Johnson
7. Insulet Corporation
8. Sensile Medical Ag
9. Becton
10. Dickinson And Company

For More information, Talk to Analyst @ https://bit.ly/2XqU2v4

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.